---
DrugClass: "[[Lower Gastrointestinal System Drugs]]"
SubClass: "[[Aminosalicylates]]"
DrugClassAdverse: "[[Aminosalicylates#Adverse Reactions]]"
DrugClassContra: "[[Aminosalicylates#Contraindications]]"
BrandName: Tysabri
SecondaryDrugClass: "[[Immune Blockers]]"
SecondarySubClass: "[[Monoclonal antibodies]]"
SecondaryAdverse: "[[Monoclonal antibodies#Adverse Reactions]]"
SecondaryContra: "[[Monoclonal antibodies#Contraindications]]"
ThirdDrugClass: 
ThirdSubClass: 
ThirdAdverse: 
ThirdContra: 
FourthDrugClass: 
FourthSubClass: 
FourthAdverse: 
FourthContra: 
Chapter: "39"
KindleLinkChap: "[Chapter 39](kindle://book?action=open&asin=B09FRF11YJ&location=22145)"
KindleLink: 
tags:
  - Drug
  - Pharmacology
Course: Pharmacology
ChemLink: https://pubchem.ncbi.nlm.nih.gov/#query=
aliases: 
SubCat: Biologics for Bowel Disorders
SubCat2: Multiple Sclerosis
---
```smiles

```

### Brand name
`=this.BrandName`

### Generic name
`= this.file.name`

### Drug class 
`= this.DrugClass`
	`= this.DrugClass.KindleLinkChap`
`= this.SecondaryDrugClass`
	`= this.SecondaryDrugClass.KindleLinkChap`
	
### Dosage & Usage
Crohn disease, multiple sclerosis
300 mg IV every 4 weeks

### Contraindications
See `= this.DrugClassContra`
See `= this.SecondaryContra`

### Mechanisms of Action


### Side/Adverse Effects
See `= this.DrugClassAdverse`
See `= this.SecondaryAdverse`
Headache, muscle aches, diarrhea

### Interactions

`= this.ChemLink+this.file.name`
